A detailed history of Ubs Group Ag transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Ubs Group Ag holds 91,000 shares of TMO stock, worth $51.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
91,000
Previous 2,098,314 95.66%
Holding current value
$51.7 Million
Previous $1.11 Billion 95.25%
% of portfolio
0.01%
Previous 0.34%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$528.82 - $599.43 $101 Million - $115 Million
191,876 Added 9.14%
2,290,190 $1.33 Billion
Q4 2023

Feb 09, 2024

BUY
$431.41 - $532.94 $24 Million - $29.7 Million
55,668 Added 2.73%
2,098,314 $1.11 Billion
Q3 2023

Nov 09, 2023

SELL
$498.29 - $574.41 $32.6 Million - $37.5 Million
-65,347 Reduced 3.1%
2,042,646 $1.03 Billion
Q2 2023

Aug 11, 2023

BUY
$508.46 - $591.13 $19.2 Million - $22.3 Million
37,752 Added 1.82%
2,107,993 $1.1 Billion
Q1 2023

May 12, 2023

BUY
$535.0 - $604.82 $100 Million - $113 Million
187,629 Added 9.97%
2,070,241 $1.19 Billion
Q4 2022

Feb 08, 2023

BUY
$484.71 - $571.37 $40.1 Million - $47.3 Million
82,745 Added 4.6%
1,882,612 $1.04 Billion
Q3 2022

Nov 10, 2022

SELL
$507.19 - $604.49 $58.5 Million - $69.7 Million
-115,382 Reduced 6.02%
1,799,867 $913 Million
Q2 2022

Aug 10, 2022

SELL
$500.9 - $612.21 $124 Million - $152 Million
-247,659 Reduced 11.45%
1,915,249 $1.04 Billion
Q1 2022

May 16, 2022

BUY
$524.0 - $644.92 $22 Million - $27.1 Million
41,987 Added 1.98%
2,162,908 $1.28 Billion
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $95 Million - $111 Million
-167,010 Reduced 7.3%
2,120,921 $1.42 Billion
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $5.4 Million - $6.46 Million
-10,592 Reduced 0.46%
2,287,931 $1.31 Billion
Q2 2021

Aug 13, 2021

SELL
$441.0 - $508.24 $69.7 Million - $80.3 Million
-158,057 Reduced 6.43%
2,298,523 $1.16 Billion
Q1 2021

May 12, 2021

SELL
$439.85 - $518.83 $116 Million - $137 Million
-264,486 Reduced 9.72%
2,456,580 $1.12 Billion
Q4 2020

Feb 11, 2021

BUY
$435.06 - $527.66 $33.8 Million - $41 Million
77,644 Added 2.94%
2,721,066 $1.27 Billion
Q3 2020

Nov 12, 2020

SELL
$359.77 - $441.52 $68.2 Million - $83.7 Million
-189,620 Reduced 6.69%
2,643,422 $1.17 Billion
Q2 2020

Jul 31, 2020

SELL
$275.2 - $362.34 $62.2 Million - $81.9 Million
-226,106 Reduced 7.39%
2,833,042 $1.03 Billion
Q1 2020

May 01, 2020

SELL
$255.3 - $340.05 $81 Million - $108 Million
-317,285 Reduced 9.4%
3,059,148 $868 Million
Q4 2019

Feb 14, 2020

BUY
$271.93 - $328.04 $10.8 Million - $13 Million
39,759 Added 1.19%
3,376,433 $1.1 Billion
Q3 2019

Nov 14, 2019

SELL
$268.46 - $305.43 $45.8 Million - $52.1 Million
-170,464 Reduced 4.86%
3,336,674 $972 Million
Q2 2019

Aug 14, 2019

BUY
$257.51 - $295.55 $61.9 Million - $71.1 Million
240,526 Added 7.36%
3,507,138 $1.03 Billion
Q1 2019

May 14, 2019

SELL
$212.17 - $273.72 $16.1 Million - $20.8 Million
-76,006 Reduced 2.27%
3,266,612 $894 Million
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $34 Million - $41.1 Million
163,089 Added 5.13%
3,342,618 $748 Million
Q3 2018

Nov 14, 2018

BUY
$205.57 - $244.32 $20.3 Million - $24.2 Million
98,989 Added 3.21%
3,179,529 $776 Million
Q2 2018

Aug 14, 2018

BUY
$203.14 - $219.53 $14.3 Million - $15.5 Million
70,574 Added 2.34%
3,080,540 $638 Million
Q1 2018

May 15, 2018

BUY
$192.98 - $224.11 $2.47 Million - $2.86 Million
12,780 Added 0.43%
3,009,966 $621 Million
Q4 2017

Feb 14, 2018

BUY
$182.03 - $200.37 $2 Million - $2.21 Million
11,011 Added 0.37%
2,997,186 $569 Million
Q3 2017

Nov 14, 2017

SELL
$171.74 - $194.04 $4.5 Million - $5.08 Million
-26,191 Reduced 0.87%
2,986,175 $565 Million
Q2 2017

Aug 14, 2017

BUY
N/A
53,592 Added 1.81%
3,012,366 $526 Million
Q1 2017

Nov 14, 2017

BUY
N/A
2,958,774
2,958,774 $454 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $223B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.